|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets including amounts of the consolidated variable interest entities (the “VIEs”) and consolidated assets backed financing entities (“ABFE”) (Note 2): | |||||||||||
| Trading securities | |||||||||||
| Cash and cash equivalents | |||||||||||
| Restricted cash | |||||||||||
| Accounts receivable (net of allowance of RMB154,925 and RMB148,880 as of December 31, 2024 and 2025, respectively) | |||||||||||
| Guarantee receivable (net of allowance of RMB3,331 and RMB63,659 as of December 31, 2023 and 2024, respectively) | |||||||||||
| Guarantee receivable (net of allowance of RMB63,659 and RMB252,321 as of December 31, 2024 and 2025, respectively) | |||||||||||
| Contract assets, net (net of allowance of RMB117,716 and RMB163,383 as of December 31, 2024 and 2025, respectively) | |||||||||||
| Contract cost | |||||||||||
| Prepaid expenses and other assets | |||||||||||
| Loans at fair value | |||||||||||
| Financing receivables (net of allowance of RMB51,858 and RMB119,185 as of December 31, 2023 and 2024, respectively) | |||||||||||
| Financing receivables (net of allowance of RMB119,185 and RMB363,322 as of December 31, 2024 and 2025, respectively) | |||||||||||
| Amounts due from related parties | |||||||||||
| Held-to-maturity investments | |||||||||||
| Other financial investments | |||||||||||
| Equity Investment | |||||||||||
| Financial investments | |||||||||||
| Equity Investments | |||||||||||
| Property, equipment and software, net | |||||||||||
| Digital assets | |||||||||||
| Deferred tax assets | |||||||||||
| Right-of-use assets | |||||||||||
| Total assets | |||||||||||
| Liabilities including amounts of the consolidated VIEs and the consolidated ABFE without recourse to the Company (Note 2): | |||||||||||
| Accounts payable | |||||||||||
| Amounts due to related parties | |||||||||||
| Related Party | |||||||||||
| Investors | |||||||||||
| Guarantee liabilities-stand ready | |||||||||||
| Guarantee liabilities-contingent | |||||||||||
| Deferred revenue | |||||||||||
| Payable to investors of the consolidated ABFE | |||||||||||
| Accrued expenses and other liabilities | |||||||||||
| Secured borrowings | |||||||||||
| Deferred tax liabilities | |||||||||||
| Lease liabilities | |||||||||||
| Total liabilities | |||||||||||
| Equity: | |||||||||||
| Ordinary shares (US$0.0001 par value; 500,000,000 shares authorized; 202,877,426 and 204,962,934 shares issued as of December 31, 2024 and 2025, respectively; 172,605,774 and 174,680,826 shares outstanding as of December 31, 2024 and 2025, respectively) | |||||||||||
| Treasury stock (7,381,472 and 11,711,652 shares as of December 31, 2023 and 2024, respectively) | |||||||||||
| Treasury stock (11,711,652 and 11,722,108 shares as of December 31, 2024 and 2025, respectively) | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Retained earnings | |||||||||||
| Total equity | |||||||||||
| Total liabilities and equity | |||||||||||
Loading...
